SCHEMBL2015901

SCHEMBL2015901

Fc1cccc(-c2c(CCNc3ncnc4[nH]cnc34)ccc3ccccc23)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.48
HTT P42858 3/20 0.48
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
PIK3CD O00329 5/20 0.42
MAP4K4 O95819 6/20 0.41
PIK3CG P48736 1/20 0.40
MAPT P10636 1/20 0.38
GFER P55789 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SYK P43405 1/20 0.38
AURKA O14965 1/20 0.37
DAPK3 O43293 1/20 0.37
JAK2 O60674 1/20 0.37
PRKD3 O94806 1/20 0.37
PAK4 O96013 1/20 0.37
ABL1 P00519 1/20 0.37
LCK P06239 1/20 0.37
CSF1R P07333 1/20 0.37
RET P07949 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2053387 0.89 MAPK1 (0.44) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL2054366 0.89 LMNA (0.40) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL2013295 0.88 PIK3CD (0.53) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL2051140 0.86 PIK3CD (0.45) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL2016100 0.86 MAP4K4 (0.40) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL2718228 0.82 MAP4K4 (0.42) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL2019256 0.81 MAP4K4 (0.42) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL2014851 0.81 PIK3CD (0.46) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL2016210 0.80 PIK3CD (0.55) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL2014148 0.80 PIK3CD (0.47) MAPK1HTTLMNASMN1; SMN2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed